+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hip Osteoarthritis Pain Drug Market - Global Forecast 2025-2030- Product Image
Hip Osteoarthritis Pain Drug Market - Global Forecast 2025-2030- Product Image
Sale

Hip Osteoarthritis Pain Drug Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6139349
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hip osteoarthritis pain therapeutics market is evolving with innovative treatment approaches, shifting care delivery models, and dynamic global supply chains. Growing demand for effective therapies and the impact of tariffs are reshaping investment priorities for industry leaders. Understanding stakeholder needs, regulatory changes, and regional dynamics is essential to navigate this period of accelerated change.

Market Snapshot of Hip Osteoarthritis Pain Therapeutics

The hip osteoarthritis pain therapeutics market is advancing as new biologics, combination treatments, and digital health platforms disrupt traditional strategies. Sustained-release injectable formulations and bioengineered hydrogel scaffolds are influencing care decisions among clinicians and patients. The maturity of reimbursement systems in the Americas and rising clinical trial activity in Asia-Pacific highlight contrasting market maturity and growth potential. Heightened payer scrutiny and cost containment policies are shaping product development and market access. Integration of digital monitoring tools enables real-time adherence and outcomes tracking, with care increasingly extending outside traditional clinical settings. Ongoing collaboration among pharmaceutical, technology, and regulatory stakeholders continues to accelerate the development and adoption of emerging solutions.

Scope & Segmentation: Hip Osteoarthritis Pain Therapeutics Market

  • Mechanism Of Action: Corticosteroids, Hyaluronic Acid, Nonsteroidal Anti-Inflammatory Drugs, Opioids, Serotonin Norepinephrine Reuptake Inhibitors
  • Route Of Administration: Injectable, Oral, Topical, Transdermal
  • End User: Ambulatory Care Centers, Home Care Settings, Hospital Pharmacies, Specialty Clinics
  • Patient Age Group: 18 To 45 Years, 46 To 60 Years, Over 60 Years
  • Geographic Coverage: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Pfizer Inc., Novartis AG, Bayer AG, GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Sanofi S.A., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Viatris Inc.

Key Takeaways for Senior Decision-Makers

  • Emerging biologic therapies and advanced delivery systems are addressing gaps in durability and safety, raising expectations for long-term symptom management.
  • Cost containment pressures are leading payers to demand evidence of real-world outcomes and longer-term value over conventional anti-inflammatory agents.
  • Tariff fluctuations are prompting a strategic shift toward vertical integration, diversified sourcing, and localized production to secure resilient supply chains in 2025.
  • Integrated digital health platforms are expanding, enabling real-time monitoring of patient adherence and symptom control beyond clinical environments.
  • Collaboration across clinical research, technology development, and regulatory agencies is expediting new product approvals and hybrid therapeutic solutions.
  • Regional strategies are crucial, as regulatory, infrastructure, and reimbursement variations influence both product adoption and competitive positioning across key markets.

Tariff Impact: US Hip Osteoarthritis Pain Therapeutics Market in 2025

Recent US tariffs on imported active pharmaceutical ingredients and excipients have increased operational complexity for manufacturers of hip osteoarthritis pain therapeutics. Companies are reevaluating procurement strategies by partnering with domestic suppliers and exploring localized manufacturing. Reformulation of existing products and optimization of supply networks support consistent product availability while maintaining safety and efficacy standards. Enhanced supply chain agility is mitigating patient access risks and maintaining continuity of care amid evolving trade policies.

Methodology & Data Sources

This report utilizes a mixed-methods approach, integrating primary interviews with key opinion leaders, formulary committee members, clinical trial investigators, and payers in major regions. Secondary research draws from peer-reviewed journals, regulatory filings, company reports, and respected industry publications. Quantitative triangulation and qualitative thematic analysis underpin multi-layer data validation to ensure findings reflect real-world dynamics and market trends.

Why This Report Matters to Industry Leaders

  • Supports risk mitigation by identifying tariff and supply chain challenges alongside actionable strategies for localization and procurement diversification.
  • Provides a detailed landscape of treatment modalities, regulatory drivers, and evolving care models for informed portfolio expansion and regional market entry.
  • Enables effective decision-making through robust, evidence-based insights into patient-centric solutions and value-based reimbursement trends.

Conclusion

As the hip osteoarthritis pain therapeutics landscape transforms, companies equipped with agile supply strategies and collaborative innovation platforms stand positioned for leadership. Senior decision-makers will benefit by focusing on localized manufacturing, technology integration, and regionalized market access. This report delivers the insights needed for strategic positioning in an increasingly complex and opportunity-rich market.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of personalized hip osteoarthritis pain management through biomarker-driven therapies
5.2. Integration of wearable sensor technology for real-time monitoring of hip osteoarthritis pain and mobility
5.3. Emergence of targeted gene therapies aiming to regenerate hip cartilage in osteoarthritis patients
5.4. Advancements in minimally invasive injection techniques delivering sustained-release analgesics to the hip joint
5.5. Growing adoption of digital health platforms for remote management and patient engagement in hip osteoarthritis treatment
5.6. Development of novel dual-action small molecules addressing both pain and cartilage degradation in hip osteoarthritis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hip Osteoarthritis Pain Drug Market, by Mechanism Of Action
8.1. Introduction
8.2. Corticosteroids
8.3. Hyaluronic Acid
8.4. Nonsteroidal Anti-Inflammatory Drugs
8.5. Opioids
8.6. Serotonin Norepinephrine Reuptake Inhibitors
9. Hip Osteoarthritis Pain Drug Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
9.5. Transdermal
10. Hip Osteoarthritis Pain Drug Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Home Care Settings
10.4. Hospital Pharmacies
10.5. Specialty Clinics
11. Hip Osteoarthritis Pain Drug Market, by Patient Age Group
11.1. Introduction
11.2. 18 To 45 Years
11.3. 46 To 60 Years
11.4. Over 60 Years
12. Americas Hip Osteoarthritis Pain Drug Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Hip Osteoarthritis Pain Drug Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Hip Osteoarthritis Pain Drug Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. Novartis AG
15.3.3. Bayer AG
15.3.4. GlaxoSmithKline plc
15.3.5. Johnson & Johnson
15.3.6. Merck & Co., Inc.
15.3.7. Sanofi S.A.
15.3.8. AstraZeneca PLC
15.3.9. Teva Pharmaceutical Industries Ltd
15.3.10. Viatris Inc.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. HIP OSTEOARTHRITIS PAIN DRUG MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HIP OSTEOARTHRITIS PAIN DRUG MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HIP OSTEOARTHRITIS PAIN DRUG MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HIP OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHAI
FIGURE 24. HIP OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHSTATISTICS
FIGURE 25. HIP OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHCONTACTS
FIGURE 26. HIP OSTEOARTHRITIS PAIN DRUG MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HIP OSTEOARTHRITIS PAIN DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SEROTONIN NOREPINEPHRINE REUPTAKE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SEROTONIN NOREPINEPHRINE REUPTAKE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY 18 TO 45 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY 18 TO 45 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY 46 TO 60 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY 46 TO 60 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY OVER 60 YEARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY OVER 60 YEARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 70. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 71. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 72. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 73. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 76. CANADA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 77. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 78. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 79. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 80. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 81. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 84. MEXICO HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 85. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 86. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 93. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 94. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 112. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 118. UNITED KINGDOM HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 119. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 120. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 121. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. GERMANY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 128. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 129. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 134. FRANCE HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 135. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 136. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 137. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 142. RUSSIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 143. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 144. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 145. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. ITALY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 152. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 153. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. SPAIN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 168. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. SAUDI ARABIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 176. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 182. SOUTH AFRICA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 183. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 184. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 185. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 190. DENMARK HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 191. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 192. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 193. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. NETHERLANDS HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 200. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 201. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 206. QATAR HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 207. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 208. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 209. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 214. FINLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 215. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 216. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 217. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. SWEDEN HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 224. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 225. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. NIGERIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 232. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 233. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. EGYPT HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 240. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 241. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 246. TURKEY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 247. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 248. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 249. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 254. ISRAEL HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 255. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 256. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 257. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. NORWAY HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 264. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 265. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 270. POLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 271. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 272. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 273. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. SWITZERLAND HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 280. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 286. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 287. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 288. ASIA-PACIFIC HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 289. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 290. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 291. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 296. CHINA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 297. INDIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 298. INDIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 299. INDIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. INDIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. INDIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. INDIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. INDIA HIP OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hip Osteoarthritis Pain Drug Market report include:
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sanofi S.A.
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.

Related Topics

Related Reports

Osteoarthritic Pain Drug Pipeline Analysis Report 2025 - Product Image

Osteoarthritic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Osteoarthritis Pain Drug Market - Global Forecast 2025-2030 - Product Image

Osteoarthritis Pain Drug Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025 - Product Image

Diabetic Neuropathic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Neuropathic Pain Drug Market - Global Forecast 2025-2030 - Product Image

Neuropathic Pain Drug Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Neuropathic Pain Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Neuropathic Pain Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.